Guerra Pan Advisors’s AbbVie ABBV Stock Holding History

Guerra Pan Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$764K	Sell	3,035 -1,344	-31%	-$289K	0.43%	49
2026 Q1	$952K	Buy	4,379 +148	+3%	+$32.8K	0.59%	40
2025 Q4	$967K	Hold	4,231	–	–	0.57%	39
2025 Q3	$980K	Hold	4,231	–	–	0.59%	38
2025 Q2	$785K	Hold	4,231	–	–	0.52%	46
2025 Q1	$886K	Hold	4,231	–	–	0.7%	40
2024 Q4	$752K	Hold	4,231	–	–	0.54%	47
2024 Q3	$836K	Hold	4,231	–	–	0.67%	42
2024 Q2	$726K	Hold	4,231	–	–	0.61%	46
2024 Q1	$770K	Sell	4,231 -36	-0.8%	-$6.2K	0.71%	40
2023 Q4	$661K	Hold	4,267	–	–	0.63%	50
2023 Q3	$636K	Hold	4,267	–	–	0.73%	44
2023 Q2	$575K	Hold	4,267	–	–	0.64%	49
2023 Q1	$680K	Sell	4,267 -10	-0.2%	-$1.53K	0.85%	38
2022 Q4	$691K	Hold	4,277	–	–	0.94%	38
2022 Q3	$593K	Buy	4,277 +54	+1%	+$7.75K	0.86%	42
2022 Q2	$606K	Hold	4,223	–	–	0.75%	45
2022 Q1	$666K	Hold	4,223	–	–	0.8%	40
2021 Q4	$572K	Buy	+4,223	New	+$499K	0.57%	56

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Guerra Pan Advisors's ABBV Position: Q2 2026 in Review

Guerra Pan Advisors reduced its AbbVie (ABBV) stake by 31% in Q2 2026, selling an estimated $289K and leaving 3,035 shares worth $764K. The position accounts for 0.43% of the portfolio, ranked #49.

Guerra Pan Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $980K in Q3 2025. 4,218 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Guerra Pan Advisors held 3,035 shares of AbbVie worth $764K as of Q2 2026.
Guerra Pan Advisors sold 1,344 AbbVie shares in Q2 2026, an estimated $289K.
AbbVie made up 0.43% of Guerra Pan Advisors's portfolio in Q2 2026, its #49 holding.
Guerra Pan Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
Guerra Pan Advisors's AbbVie position peaked at $980K in Q3 2025.
4,218 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Guerra Pan Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.